| (+)-pilocarpine | decreases expression | ISO | RGD:621065 | 6480464 | Pilocarpine results in decreased expression of CSF2 mRNA | CTD | PMID:17971868 |
| (+)-pilocarpine | increases expression | ISO | RGD:621065 | 6480464 | Pilocarpine results in increased expression of CSF2 mRNA | CTD | PMID:17971868 |
| (S)-colchicine | multiple interactions | ISO | RGD:1354508 | 6480464 | Colchicine inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]; more ... | CTD | PMID:18346843 |
| (S)-nicotine | multiple interactions | ISO | RGD:1354508 | 6480464 | Nicotine results in increased expression of and results in increased secretion of CSF2 protein | CTD | PMID:18082304 |
| (S)-nicotine | multiple interactions | ISO | RGD:1354508 | 6480464 | Tubocurarine inhibits the reaction [Nicotine results in increased secretion of CSF2 protein] | CTD | PMID:9606035 |
| (S)-nicotine | increases secretion | ISO | RGD:1354508 | 6480464 | Nicotine results in increased secretion of CSF2 protein | CTD | PMID:9606035 |
| 1,4-phenylenediamine | increases secretion | EXP | | 6480464 | 4-phenylenediamine results in increased secretion of CSF2 protein | CTD | PMID:22245253 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of CSF2 mRNA | CTD | PMID:18652873 |
| 1-chloro-2,4-dinitrobenzene | increases secretion | EXP | | 6480464 | Dinitrochlorobenzene results in increased secretion of CSF2 protein | CTD | PMID:22245253 |
| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSF2 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CSF2 mRNA | CTD | PMID:17942748 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | RGD:1354508 | 6480464 | Dihydrotestosterone inhibits the reaction [TNF protein results in increased secretion of CSF2 protein] | CTD | PMID:16317058 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSF2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CSF2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CSF2 mRNA | CTD | PMID:17942748 PMID:14678569 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CSF2 mRNA | CTD | PMID:14678569 PMID:17942748 |
| 2,6-di-tert-butyl-4-methylphenol | multiple interactions | EXP | | 6480464 | Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein] | CTD | PMID:16822543 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:621065 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CSF2 mRNA] | CTD | PMID:17109745 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:621065 | 6480464 | Glucosamine results in increased expression of CSF2 mRNA | CTD | PMID:17109745 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | EXP | | 6480464 | Oxazolone results in increased expression of CSF2 mRNA | CTD | PMID:18652873 |
| 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CSF2 mRNA | CTD | PMID:19191707 |
| 4-nitroquinoline N-oxide | increases expression | EXP | | 6480464 | 4-Nitroquinoline-1-oxide results in increased expression of CSF2 mRNA | CTD | PMID:22561872 |
| 4-nonylphenol | increases secretion | ISO | RGD:1354508 | 6480464 | 4-nonylphenol results in increased secretion of CSF2 protein | CTD | PMID:20194071 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of CSF2 mRNA | CTD | PMID:18344199 |
| 7,12-dimethyltetraphene | increases expression | EXP | | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of CSF2 mRNA | CTD | PMID:14678569 |
| acetaldehyde | increases secretion | ISO | RGD:1354508 | 6480464 | Acetaldehyde results in increased secretion of CSF2 protein | CTD | PMID:14619338 |
| acetylcholine | increases secretion | ISO | RGD:1354508 | 6480464 | Acetylcholine results in increased secretion of CSF2 protein | CTD | PMID:9606035 |
| acrolein | decreases secretion | ISO | RGD:1354508 | 6480464 | Acrolein results in decreased secretion of CSF2 protein | CTD | PMID:17491020 |
| actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [Reactive Oxygen Species results in increased expression of CSF2 protein] | CTD | PMID:11752025 |
| actinomycin D | multiple interactions | ISO | RGD:1354508 | 6480464 | Dactinomycin inhibits the reaction [IL1B results in increased secretion of CSF2 protein] | CTD | PMID:9606035 |
| aflatoxin B1 | increases expression | ISO | RGD:1354508 | 6480464 | Aflatoxin B1 results in increased expression of CSF2 mRNA | CTD | PMID:22100608 |
| albuterol | multiple interactions | ISO | RGD:1354508 | 6480464 | [Beclomethasone co-treated with Albuterol] results in decreased secretion of CSF2 protein | CTD | PMID:15679717 |
| alclometasone dipropionate | decreases expression | ISO | RGD:1354508 | 6480464 | alclometasone dipropionate results in decreased expression of CSF2 protein | CTD | PMID:11407316 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:621065 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CSF2 mRNA] | CTD | PMID:17109745 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:621065 | 6480464 | Glucosamine results in increased expression of CSF2 mRNA | CTD | PMID:17109745 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1354508 | 6480464 | CSF2 protein promotes the reaction [Tretinoin results in increased expression of CD83 protein] | CTD | PMID:15454112 |
| aluminium hydroxide | multiple interactions | ISO | RGD:1354508 | 6480464 | Aluminum Hydroxide inhibits the reaction [[CSF2 protein co-treated with IL4 protein] results in increased expression of CD1A protein]; more ... | CTD | PMID:18390722 |
| aluminium oxide | increases secretion | ISO | RGD:1354508 | 6480464 | Aluminum Oxide results in increased secretion of CSF2 protein | CTD | PMID:15046894 |
| ammonium chloride | affects expression | ISO | RGD:621065 | 6480464 | Ammonium Chloride affects the expression of CSF2 mRNA | CTD | PMID:16483693 |
| anthracene-1,8,9-triol | increases expression | ISO | RGD:1354508 | 6480464 | Anthralin results in increased expression of CSF2 mRNA | CTD | PMID:9628260 |
| apocynin | multiple interactions | ISO | RGD:1354508 | 6480464 | acetovanillone inhibits the reaction [TNF protein results in increased expression of CSF2 mRNA] | CTD | PMID:22414048 |
| asbestos | increases expression | ISO | RGD:1354508 | 6480464 | Asbestos results in increased expression of CSF2 mRNA | CTD | PMID:22398240 |
| baicalein | decreases expression | ISO | RGD:1354508 | 6480464 | baicalein results in decreased expression of CSF2 mRNA | CTD | PMID:10718847 |
| beclomethasone | multiple interactions | ISO | RGD:1354508 | 6480464 | [Beclomethasone co-treated with formoterol] results in decreased secretion of CSF2 protein; more ... | CTD | PMID:15679717 |
| benzene | increases expression | ISO | RGD:1354508 | 6480464 | Benzene results in increased expression of CSF2 protein | CTD | PMID:11306435 |
| benzo[a]pyrene | increases expression | ISO | RGD:1354508 | 6480464 | Benzo(a)pyrene results in increased expression of CSF2 protein | CTD | PMID:11306435 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:621065 | 6480464 | Glucosamine inhibits the reaction [IL1B results in increased expression of CSF2 mRNA] | CTD | PMID:17109745 |
| beta-D-glucosamine | increases expression | ISO | RGD:621065 | 6480464 | Glucosamine results in increased expression of CSF2 mRNA | CTD | PMID:17109745 |
| betamethasone valerate | decreases expression | ISO | RGD:1354508 | 6480464 | Betamethasone 17-Valerate results in decreased expression of CSF2 protein | CTD | PMID:11407316 |
| bilirubin | increases expression | ISO | RGD:1354508 | 6480464 | Bilirubin results in increased expression of CSF2 mRNA | CTD | PMID:20196124 |
| bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of CSF2 mRNA; more ... | CTD | PMID:11083082 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:1354508 | 6480464 | Mustard Gas results in increased expression of CSF2 protein | CTD | PMID:17894541 |
| bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [Diethylhexyl Phthalate co-treated with CSF2] results in increased expression of IFNG protein; more ... | CTD | PMID:19428943 |
| bisphenol A | decreases expression | ISO | RGD:1354508 | 6480464 | bisphenol A results in decreased expression of CSF2 mRNA | CTD | PMID:18007998 |
| bleomycin A2 | increases expression | ISO | RGD:1354508 | 6480464 | Bleomycin results in increased expression of CSF2 protein | CTD | PMID:18684396 |
| brefeldin A | multiple interactions | ISO | RGD:1354508 | 6480464 | Brefeldin A inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]; more ... | CTD | PMID:18346843 |
| budesonide | decreases secretion | ISO | RGD:1354508 | 6480464 | Budesonide results in decreased secretion of CSF2 protein | CTD | PMID:7621058 |
| cadmium atom | multiple interactions | ISO | RGD:1354508 | 6480464 | Cadmium results in increased expression of and results in increased secretion of CSF2 protein | CTD | PMID:18082304 |
| cadmium atom | affects expression | ISO | RGD:621065 | 6480464 | Cadmium affects the expression of CSF2 protein | CTD | PMID:20826145 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of CSF2 mRNA | CTD | PMID:20061341 |
| capsaicin | increases expression | ISO | RGD:621065 | 6480464 | Capsaicin results in increased expression of CSF2 protein | CTD | PMID:22150557 |
| capsaicin | multiple interactions | ISO | RGD:621065 | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CSF2 protein]; more ... | CTD | PMID:22150557 |
| carmustine | affects response to substance | ISO | RGD:1354508 | 6480464 | CSF2 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 |
| carvedilol | multiple interactions | ISO | RGD:1354508 | 6480464 | carvedilol inhibits the reaction [CSF2 results in increased expression of IL10 mRNA]; more ... | CTD | PMID:12722941 |
| chenodeoxycholic acid | multiple interactions | EXP | | 6480464 | EGR1 promotes the reaction [Chenodeoxycholic Acid results in increased expression of CSF2 mRNA] | CTD | PMID:21224055 |
| chenodeoxycholic acid | increases expression | EXP | | 6480464 | Chenodeoxycholic Acid results in increased expression of CSF2 mRNA | CTD | PMID:21224055 |
| ciprofloxacin | increases expression | EXP | | 6480464 | Ciprofloxacin results in increased expression of CSF2 protein | CTD | PMID:11125792 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of CSF2 protein | CTD | PMID:20844023 |
| clobetasol | decreases secretion | EXP | | 6480464 | Clobetasol results in decreased secretion of CSF2 protein | CTD | PMID:15086553 |
| cobalt atom | increases expression | EXP | | 6480464 | Cobalt results in increased expression of CSF2 mRNA | CTD | PMID:22147119 |
| cobalt atom | multiple interactions | EXP | | 6480464 | [Organometallic Compounds co-treated with Cobalt] results in increased expression of CSF2 mRNA | CTD | PMID:22147119 |
| cobalt atom | multiple interactions | ISO | RGD:621065 | 6480464 | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of CSF2 mRNA | CTD | PMID:22198552 |
| columbamine | multiple interactions | ISO | RGD:1354508 | 6480464 | columbamine inhibits the reaction [CSF2 protein results in increased phosphorylation of STAT3 protein] | CTD | PMID:23124089 |
| cortisol | decreases secretion | EXP | | 6480464 | Hydrocortisone results in decreased secretion of CSF2 protein | CTD | PMID:15086553 |
| crocidolite asbestos | increases expression | ISO | RGD:1354508 | 6480464 | Asbestos, Crocidolite results in increased expression of CSF2 mRNA; more ... | CTD | PMID:11250057 |
| cycloheximide | multiple interactions | ISO | RGD:1354508 | 6480464 | Cycloheximide inhibits the reaction [IL1B results in increased secretion of CSF2 protein] | CTD | PMID:9606035 |
| cyclophosphamide | affects activity | ISO | RGD:1354508 | 6480464 | CSF2 protein affects the activity of Cyclophosphamide | CTD | PMID:8349185 |
| cyclophosphamide | increases expression | ISO | RGD:621065 | 6480464 | Cyclophosphamide results in increased expression of CSF2 protein | CTD | PMID:18848347 |
| cyclosporin A | multiple interactions | EXP | | 6480464 | Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein] | CTD | PMID:1376361 |
| D-penicillamine | increases expression | ISO | RGD:621065 | 6480464 | Penicillamine results in increased expression of CSF2 mRNA | CTD | PMID:19575532 |
| dasatinib (anhydrous) | decreases expression | ISO | RGD:1354508 | 6480464 | dasatinib results in decreased expression of CSF2 protein | CTD | PMID:17962511 |
| deoxycholic acid | multiple interactions | EXP | | 6480464 | EGR1 promotes the reaction [Deoxycholic Acid results in increased expression of CSF2 mRNA] | CTD | PMID:21224055 |
| deoxycholic acid | increases expression | EXP | | 6480464 | Deoxycholic Acid results in increased expression of CSF2 mRNA | CTD | PMID:21224055 |
| desferrioxamine B | multiple interactions | ISO | RGD:1354508 | 6480464 | Deferoxamine inhibits the reaction [Particulate Matter results in increased expression of CSF2 mRNA] | CTD | PMID:20801209 PMID:21703343 |
| dexamethasone | multiple interactions | ISO | RGD:1354508 | 6480464 | Dexamethasone inhibits the reaction [IL13 protein results in increased secretion of CSF2 protein]; more ... | CTD | PMID:12077271 |
| dexamethasone | multiple interactions | ISO | RGD:1354508 | 6480464 | Dexamethasone inhibits the reaction [TNF protein results in increased secretion of CSF2 protein] | CTD | PMID:20801891 |
| dexamethasone | decreases expression | ISO | RGD:1354508 | 6480464 | Dexamethasone results in decreased expression of CSF2 mRNA | CTD | PMID:10596698 |
| dexamethasone | multiple interactions | ISO | RGD:1354508 | 6480464 | Dexamethasone inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; more ... | CTD | PMID:12070353 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | CTD | PMID:16880258 |
| dexamethasone | multiple interactions | ISO | RGD:1354508 | 6480464 | Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein] | CTD | PMID:16908450 |
| dexamethasone | multiple interactions | ISO | RGD:1354508 | 6480464 | Dexamethasone promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [IL1B protein results in increased expression of CSF2 mRNA]] | CTD | PMID:14998300 |
| dexamethasone | multiple interactions | ISO | RGD:1354508 | 6480464 | Dexamethasone inhibits the reaction [TNF protein results in increased expression of CSF2 mRNA] | CTD | PMID:19255438 |
| dextran sulfate | increases expression | EXP | | 6480464 | Dextran Sulfate results in increased expression of CSF2 mRNA | CTD | PMID:15652231 |
| dextran sulfate | multiple interactions | EXP | | 6480464 | Rutin inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 mRNA] | CTD | PMID:15652231 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1354508 | 6480464 | [arsenic trioxide co-treated with CSF2] results in decreased activity of RELA protein; more ... | CTD | PMID:16174796 |
| dichlorine | increases expression | EXP | | 6480464 | Chlorine results in increased expression of CSF2 protein | CTD | PMID:23146759 |
| docetaxel anhydrous | increases secretion | ISO | RGD:1354508 | 6480464 | docetaxel results in increased secretion of CSF2 protein | CTD | PMID:18346843 |
| ethanol | decreases secretion | EXP | | 6480464 | Ethanol results in decreased secretion of CSF2 protein | CTD | PMID:20624996 |
| ethanol | multiple interactions | EXP | | 6480464 | Ethanol inhibits the reaction [Poly I-C results in increased expression of CSF2 protein] | CTD | PMID:19500611 |
| ethyl acetate | increases expression | ISO | RGD:1354508 | 6480464 | ethyl acetate results in increased expression of CSF2 protein | CTD | PMID:11306435 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | multiple interactions | ISO | RGD:1354508 | 6480464 | Egtazic Acid inhibits the reaction [Quercetin results in increased secretion of CSF2 protein]; more ... | CTD | PMID:18346843 |
| fenofibrate | multiple interactions | ISO | RGD:621065 | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CSF2 mRNA | CTD | PMID:18253720 |
| ferroheme b | decreases expression | EXP | | 6480464 | Heme metabolite results in decreased expression of CSF2 mRNA | CTD | PMID:19191707 |
| formaldehyde | multiple interactions | ISO | RGD:1354508 | 6480464 | Formaldehyde results in increased expression of and results in increased secretion of CSF2 protein | CTD | PMID:18082304 |
| formoterol | multiple interactions | ISO | RGD:1354508 | 6480464 | [Beclomethasone co-treated with formoterol] results in decreased secretion of CSF2 protein | CTD | PMID:15679717 |
| gold atom | multiple interactions | EXP | | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CSF2 protein | CTD | PMID:22155353 |
| gold atom | increases secretion | EXP | | 6480464 | Gold results in increased secretion of CSF2 protein | CTD | PMID:22155353 |
| gold(0) | multiple interactions | EXP | | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CSF2 protein | CTD | PMID:22155353 |
| gold(0) | increases secretion | EXP | | 6480464 | Gold results in increased secretion of CSF2 protein | CTD | PMID:22155353 |
| histamine | increases expression | ISO | RGD:1354508 | 6480464 | Histamine results in increased expression of CSF2 protein | CTD | PMID:9856766 |
| histamine | increases secretion | ISO | RGD:1354508 | 6480464 | Histamine results in increased secretion of CSF2 protein | CTD | PMID:9606035 |
| hydrogen peroxide | increases expression | ISO | RGD:1354508 | 6480464 | Hydrogen Peroxide results in increased expression of CSF2 mRNA | CTD | PMID:11378323 |
| hydroquinone | multiple interactions | ISO | RGD:1354508 | 6480464 | [CSF2 protein co-treated with hydroquinone] results in increased phosphorylation of and results in increased activity of MAPK1 protein; more ... | CTD | PMID:15129224 |
| indomethacin | increases expression | ISO | RGD:1354508 | 6480464 | Indomethacin results in increased expression of CSF2 mRNA | CTD | PMID:16984733 |
| ionomycin | multiple interactions | ISO | RGD:1354508 | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CSF2 protein | CTD | PMID:17572062 |
| iron atom | multiple interactions | ISO | RGD:621065 | 6480464 | [Nickel co-treated with Iron co-treated with Tungsten] results in increased expression of CSF2 mRNA | CTD | PMID:22198552 |
| isotretinoin | decreases secretion | ISO | RGD:621065 | 6480464 | Isotretinoin results in decreased secretion of CSF2 protein | CTD | PMID:15972972 |
| kaempferol | multiple interactions | ISO | RGD:1354508 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]; more ... | CTD | PMID:18346843 |
| kaempferol | increases secretion | ISO | RGD:1354508 | 6480464 | kaempferol results in increased secretion of CSF2 protein | CTD | PMID:18346843 |
| lead diacetate | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with lead acetate co-treated with CSF2 protein] results in increased expression of CD40 protein; more ... | CTD | PMID:17512567 |
| lead(0) | multiple interactions | EXP | | 6480464 | [Lead co-treated with CSF2 protein] results in decreased expression of ITGAX protein | CTD | PMID:17512567 |
| leukotriene B4 | increases secretion | ISO | RGD:1354508 | 6480464 | Leukotriene B4 results in increased secretion of CSF2 protein | CTD | PMID:15136573 |
| leukotriene D4 | multiple interactions | ISO | RGD:1354508 | 6480464 | Leukotriene D4 promotes the reaction [CSF2 protein results in increased expression of TGFB1 protein] | CTD | PMID:15947480 |
| luteolin | decreases expression | ISO | RGD:1354508 | 6480464 | Luteolin results in decreased expression of CSF2 mRNA | CTD | PMID:10718847 |
| luteolin | multiple interactions | ISO | RGD:621065 | 6480464 | Luteolin inhibits the reaction [Calcimycin results in increased expression of CSF2 mRNA] | CTD | PMID:17950587 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [PTPN11 protein mutant form results in increased susceptibility to CSF2 protein] | CTD | PMID:22315502 |
| mangiferin | multiple interactions | EXP | | 6480464 | mangiferin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CSF2 protein] | CTD | PMID:15135318 |
| mangiferin | decreases expression | EXP | | 6480464 | mangiferin results in decreased expression of CSF2 mRNA | CTD | PMID:15135318 |
| mercury dichloride | increases expression | EXP | | 6480464 | Mercuric Chloride results in increased expression of CSF2 protein | CTD | PMID:21984480 |
| methanol | increases expression | ISO | RGD:1354508 | 6480464 | Methanol results in increased expression of CSF2 protein | CTD | PMID:11306435 |
| microcystin-LR | multiple interactions | EXP | | 6480464 | cyanoginosin LR inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | CTD | PMID:15712326 |
| monensin A | multiple interactions | ISO | RGD:1354508 | 6480464 | Monensin inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]; more ... | CTD | PMID:18346843 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1354508 | 6480464 | Acetylcysteine inhibits the reaction [Particulate Matter results in increased secretion of CSF2 protein] | CTD | PMID:19460412 |
| N-methyl-N-nitrosurea | multiple interactions | EXP | | 6480464 | Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein]; more ... | CTD | PMID:16822543 |
| N-methyl-N-nitrosurea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of CSF2 protein | CTD | PMID:16822543 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:621065 | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CSF2 mRNA | CTD | PMID:18253720 |
| NAD zwitterion | multiple interactions | EXP | | 6480464 | [NAD results in increased abundance of Reactive Oxygen Species] which results in increased expression of CSF2 protein | CTD | PMID:11752025 |
| NAD(+) | multiple interactions | EXP | | 6480464 | [NAD results in increased abundance of Reactive Oxygen Species] which results in increased expression of CSF2 protein | CTD | PMID:11752025 |
| naproxen | multiple interactions | ISO | RGD:621065 | 6480464 | [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CSF2 protein]; more ... | CTD | PMID:22150557 |
| nickel atom | multiple interactions | ISO | RGD:621065 | 6480464 | [Nickel co-treated with Iron co-treated with Tungsten] results in increased expression of CSF2 mRNA; more ... | CTD | PMID:22198552 |
| nickel dichloride | increases expression | ISO | RGD:1354508 | 6480464 | nickel chloride results in increased expression of CSF2 protein | CTD | PMID:21569788 |
| nickel dichloride | increases expression | ISO | RGD:1354508 | 6480464 | nickel chloride results in increased expression of CSF2 mRNA | CTD | PMID:17312168 |
| nitric oxide | multiple interactions | ISO | RGD:621065 | 6480464 | CSF2 protein promotes the reaction [ITGB2 protein results in increased abundance of Nitric Oxide]; more ... | CTD | PMID:8600936 |
| nitro blue tetrazolium dichloride | multiple interactions | ISO | RGD:1354508 | 6480464 | CSF2 protein affects the susceptibility to [Nitroblue Tetrazolium co-treated with methyl 2,5-dihydroxycinnamate]; more ... | CTD | PMID:8471626 |
| nitro blue tetrazolium dichloride | affects response to substance | ISO | RGD:1354508 | 6480464 | CSF2 protein affects the susceptibility to Nitroblue Tetrazolium | CTD | PMID:8471626 |
| nocodazole | multiple interactions | ISO | RGD:1354508 | 6480464 | Nocodazole inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]; more ... | CTD | PMID:18346843 |
| ozone | multiple interactions | ISO | RGD:621065 | 6480464 | Ozone promotes the reaction [[CSF2 protein results in increased expression of ITGB2 protein] which results in increased abundance of Nitric Oxide] | CTD | PMID:8600936 |
| ozone | decreases expression | ISO | RGD:621065 | 6480464 | Ozone results in decreased expression of CSF2 mRNA | CTD | PMID:16330353 |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of CSF2 protein | CTD | PMID:18315731 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CSF2 mRNA | CTD | PMID:20363829 |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of CSF2 mRNA | CTD | PMID:22938100 |
| phenethyl isothiocyanate | multiple interactions | EXP | | 6480464 | phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | CTD | PMID:20423518 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1354508 | 6480464 | [Lipopolysaccharides co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein; more ... | CTD | PMID:17051331 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CSF2 protein | CTD | PMID:11752025 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | Cyclosporine inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein]; more ... | CTD | PMID:1376361 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | 1,3-dimethylthiourea inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CSF2 protein] | CTD | PMID:11752025 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1354508 | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CSF2 mRNA | CTD | PMID:16979875 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1354508 | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CSF2 protein | CTD | PMID:17572062 |
| poly(ethylene) | affects secretion | ISO | RGD:1354508 | 6480464 | Polyethylene affects the secretion of CSF2 protein | CTD | PMID:15046894 |
| propan-2-ol | increases secretion | EXP | | 6480464 | 2-Propanol results in increased secretion of CSF2 protein | CTD | PMID:22245253 |
| prostaglandin E2 | multiple interactions | EXP | | 6480464 | CSF2 protein promotes the reaction [Dinoprostone results in increased expression of [IL12B protein binds to IL23A protein]] | CTD | PMID:15180965 |
| prostaglandin E2 | multiple interactions | ISO | RGD:1354508 | 6480464 | [IL4 protein co-treated with CSF2 protein co-treated with TNF protein co-treated with Dinoprostone co-treated with IL1B protein co-treated with IL6 protein] results in increased expression of MUC1 protein; more ... | CTD | PMID:18952292 |
| quercetin | multiple interactions | ISO | RGD:1354508 | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Quercetin results in increased secretion of CSF2 protein]; more ... | CTD | PMID:18346843 |
| quercetin | increases secretion | ISO | RGD:1354508 | 6480464 | Quercetin results in increased secretion of CSF2 protein | CTD | PMID:18346843 |
| quercetin | multiple interactions | ISO | RGD:1354508 | 6480464 | Quercetin inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | CTD | PMID:15180920 |
| quercetin | decreases expression | ISO | RGD:1354508 | 6480464 | Quercetin results in decreased expression of CSF2 mRNA | CTD | PMID:10718847 |
| raloxifene | multiple interactions | ISO | RGD:1354508 | 6480464 | [Raloxifene co-treated with ESR1 protein] results in decreased expression of CSF2 mRNA | CTD | PMID:19059307 |
| resveratrol | multiple interactions | ISO | RGD:1354508 | 6480464 | resveratrol inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | CTD | PMID:15180920 |
| resveratrol | multiple interactions | ISO | RGD:1354508 | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased secretion of CSF2 protein] | CTD | PMID:20801891 |
| resveratrol | increases expression | ISO | RGD:1354508 | 6480464 | resveratrol results in increased expression of CSF2 mRNA | CTD | PMID:15280659 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol analog results in decreased expression of CSF2 mRNA | CTD | PMID:15652768 |
| rutin | multiple interactions | EXP | | 6480464 | Rutin inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 mRNA] | CTD | PMID:15652231 |
| salmeterol | multiple interactions | ISO | RGD:1354508 | 6480464 | salmeterol inhibits the reaction [Antigens, Dermatophagoides results in increased secretion of CSF2 protein] | CTD | PMID:9344832 |
| scopolamine | multiple interactions | EXP | | 6480464 | IL1RN protein inhibits the reaction [CSF2 protein results in decreased susceptibility to Scopolamine Hydrobromide] | CTD | PMID:8877002 |
| scopolamine | decreases response to substance | EXP | | 6480464 | CSF2 protein results in decreased susceptibility to Scopolamine Hydrobromide | CTD | PMID:8877002 |
| silicon dioxide | increases expression | ISO | RGD:1354508 | 6480464 | Silicon Dioxide results in increased expression of CSF2 mRNA | CTD | PMID:21540303 |
| silicon dioxide | multiple interactions | EXP | | 6480464 | [Gold co-treated with Silicon Dioxide] results in increased secretion of CSF2 protein | CTD | PMID:22155353 |
| sirolimus | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]] | CTD | PMID:1376361 |
| sodium dodecyl sulfate | increases expression | ISO | RGD:1354508 | 6480464 | Sodium Dodecyl Sulfate results in increased expression of CSF2 mRNA | CTD | PMID:11378323 |
| sodium dodecyl sulfate | increases secretion | EXP | | 6480464 | Sodium Dodecyl Sulfate results in increased secretion of CSF2 protein | CTD | PMID:22245253 |
| spironolactone | multiple interactions | ISO | RGD:1354508 | 6480464 | Spironolactone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CSF2 protein] | CTD | PMID:17051331 |
| staurosporine | multiple interactions | ISO | RGD:1354508 | 6480464 | CSF2 protein affects the susceptibility to [Nitroblue Tetrazolium co-treated with Staurosporine] | CTD | PMID:8471626 |
| sulfasalazine | multiple interactions | ISO | RGD:1354508 | 6480464 | Sulfasalazine inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Lipopolysaccharides] results in increased expression of CSF2 protein] | CTD | PMID:17051331 |
| sumatriptan | multiple interactions | ISO | RGD:621065 | 6480464 | Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CSF2 protein]; more ... | CTD | PMID:22150557 |
| tacrolimus hydrate | decreases expression | ISO | RGD:1354508 | 6480464 | Tacrolimus results in decreased expression of CSF2 protein | CTD | PMID:11407316 |
| tacrolimus hydrate | multiple interactions | EXP | | 6480464 | Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]]; more ... | CTD | PMID:1376361 |
| tamoxifen | multiple interactions | ISO | RGD:1354508 | 6480464 | [Tamoxifen co-treated with ESR1 protein] results in decreased expression of CSF2 mRNA | CTD | PMID:19059307 |
| taurocholic acid | multiple interactions | EXP | | 6480464 | EGR1 promotes the reaction [Taurocholic Acid results in increased expression of CSF2 mRNA] | CTD | PMID:21224055 |
| taurocholic acid | increases expression | EXP | | 6480464 | Taurocholic Acid results in increased expression of CSF2 mRNA | CTD | PMID:21224055 |
| temozolomide | affects response to substance | ISO | RGD:1354508 | 6480464 | CSF2 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 |
| thalidomide | decreases activity | ISO | RGD:1354508 | 6480464 | Thalidomide results in decreased activity of CSF2 protein | CTD | PMID:17557286 |
| theophylline | multiple interactions | ISO | RGD:1354508 | 6480464 | [Theophylline co-treated with Dexamethasone] inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; more ... | CTD | PMID:12070353 |
| theophylline | decreases expression | ISO | RGD:1354508 | 6480464 | Theophylline results in decreased expression of CSF2 mRNA | CTD | PMID:10596698 |
| theophylline | multiple interactions | ISO | RGD:1354508 | 6480464 | Theophylline inhibits the reaction [CSF2 protein results in increased expression of EDN1 mRNA] | CTD | PMID:10374451 |
| titanium dioxide | increases secretion | ISO | RGD:1354508 | 6480464 | titanium dioxide results in increased secretion of CSF2 protein | CTD | PMID:19464580 |
| titanium dioxide | increases expression | ISO | RGD:1354508 | 6480464 | titanium dioxide results in increased expression of CSF2 mRNA | CTD | PMID:19464580 PMID:19695317 |
| titanium dioxide | increases secretion | ISO | RGD:1354508 | 6480464 | titanium dioxide results in increased secretion of CSF2 protein | CTD | PMID:19464580 PMID:20005940 |
| titanium dioxide | increases expression | ISO | RGD:1354508 | 6480464 | titanium dioxide results in increased expression of CSF2 mRNA | CTD | PMID:19464580 |
| toluene 2,4-diisocyanate | multiple interactions | ISO | RGD:1354508 | 6480464 | Dexamethasone inhibits the reaction [[Toluene 2,4-Diisocyanate binds to ALB protein] which results in increased expression of CSF2 protein]; more ... | CTD | PMID:16908450 |
| trans-resveratrol | multiple interactions | ISO | RGD:1354508 | 6480464 | resveratrol inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein] | CTD | PMID:15180920 |
| trans-resveratrol | multiple interactions | ISO | RGD:1354508 | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased secretion of CSF2 protein] | CTD | PMID:20801891 |
| trans-resveratrol | increases expression | ISO | RGD:1354508 | 6480464 | resveratrol results in increased expression of CSF2 mRNA | CTD | PMID:15280659 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol analog results in decreased expression of CSF2 mRNA | CTD | PMID:15652768 |
| trichostatin A | multiple interactions | ISO | RGD:1354508 | 6480464 | [trichostatin A co-treated with Dexamethasone] inhibits the reaction [IL1B protein promotes the reaction [HIST4H4 protein modified form binds to CSF2 promoter]]; more ... | CTD | PMID:12070353 |
| triclosan | multiple interactions | ISO | RGD:1354508 | 6480464 | Triclosan inhibits the reaction [Lipopolysaccharides results in increased expression of CSF2 mRNA] | CTD | PMID:20507366 |
| troglitazone | increases expression | ISO | RGD:1354508 | 6480464 | troglitazone results in increased expression of CSF2 mRNA | CTD | PMID:19631733 |
| tubocurarine | multiple interactions | ISO | RGD:1354508 | 6480464 | Tubocurarine inhibits the reaction [Nicotine results in increased secretion of CSF2 protein] | CTD | PMID:9606035 |
| tungsten atom | multiple interactions | ISO | RGD:621065 | 6480464 | [Nickel co-treated with Cobalt co-treated with Tungsten] results in increased expression of CSF2 mRNA; more ... | CTD | PMID:22198552 |
| urethane | multiple interactions | ISO | RGD:1354508 | 6480464 | Urethane results in increased expression of and results in increased secretion of CSF2 protein | CTD | PMID:18082304 |
| urethane | multiple interactions | EXP | | 6480464 | IFNG protein inhibits the reaction [Urethane results in decreased expression of CSF2 mRNA]; more ... | CTD | PMID:12810352 |
| urethane | multiple interactions | EXP | | 6480464 | [Urethane co-treated with Freund's Adjuvant] results in increased expression of CSF2 mRNA | CTD | PMID:12400877 |
| vanadyl sulfate | increases expression | ISO | RGD:1354508 | 6480464 | vanadyl sulfate results in increased expression of CSF2 protein | CTD | PMID:18684396 |
| zidovudine | multiple interactions | EXP | | 6480464 | [IL3 protein co-treated with CSF2 protein] inhibits the reaction [Zidovudine results in decreased expression of CSF2RA mRNA]; more ... | CTD | PMID:12084393 |
| zinc atom | multiple interactions | ISO | RGD:1354508 | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CSF2 mRNA | CTD | PMID:16979875 |
| zinc dichloride | increases expression | ISO | RGD:1354508 | 6480464 | zinc chloride results in increased expression of CSF2 mRNA | CTD | PMID:21540303 |
| zinc dichloride | increases expression | EXP | | 6480464 | zinc chloride results in increased expression of CSF2 protein | CTD | PMID:18509044 |
| zinc dichloride | multiple interactions | EXP | | 6480464 | N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [zinc chloride results in increased expression of CSF2 protein]; more ... | CTD | PMID:18509044 |
| zinc(0) | multiple interactions | ISO | RGD:1354508 | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CSF2 mRNA | CTD | PMID:16979875 |